Tufton Capital Management Organon & Co. Transaction History

Tufton Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$30.45 - $39.36 $232,303 - $300,277	-7,629 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$28.67 - $37.13 $87,529 - $113,357	-3,053 Reduced 28.58%	7,629 $232,000
Q3 2021 Oct 21, 2021	SELL	$28.63 - $35.64 $61,697 - $76,804	-2,155 Reduced 16.79%	10,682 $350,000
Q2 2021 Jul 29, 2021	BUY	$28.45 - $38.0 $365,212 - $487,806	12,837 New	12,837 $388,000

790

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.03B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Tufton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Tufton Capital Management with notifications on news.